-
Signature
-
/s/ Katherine A. Krebel, Attorney-in-Fact
-
Stock symbol
-
DRS
-
Transactions as of
-
Nov 29, 2024
-
Transactions value $
-
-$2,032,428
-
Form type
-
4
-
Date filed
-
12/3/2024, 05:59 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+44.6K |
+261.14% |
$0.00 |
61.6K |
Nov 29, 2024 |
Direct |
F1 |
transaction |
DRS |
Common Stock |
Tax liability |
-$749K |
-21.5K |
-34.93% |
$34.77 |
40.1K |
Nov 29, 2024 |
Direct |
F2 |
transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+29.7K |
+74.08% |
$0.00 |
69.8K |
Nov 29, 2024 |
Direct |
F3 |
transaction |
DRS |
Common Stock |
Tax liability |
-$499K |
-14.4K |
-20.56% |
$34.77 |
55.5K |
Nov 29, 2024 |
Direct |
F2 |
transaction |
DRS |
Common Stock |
Sale |
-$785K |
-23K |
-41.54% |
$34.06 |
32.4K |
Dec 2, 2024 |
Direct |
F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DRS |
Performance Restricted Stock Unit |
Options Exercise |
$0 |
-44.6K |
-100% |
$0.00 |
0 |
Nov 29, 2024 |
Common Stock |
44.6K |
|
Direct |
F1 |
transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-29.7K |
-100% |
$0.00 |
0 |
Nov 29, 2024 |
Common Stock |
29.7K |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: